CLINICAL_TRIALS
trial_result
· 2016-03-15
Clinical Trial Update: A Study of Xeloda (Capecitabine) Plus Radiation Therapy in Children With Newly Diagnosed Gliomas [Phase 1]
Summary
Phase 1 study evaluating capecitabine (Xeloda) plus radiation therapy in children with newly diagnosed gliomas; the trial is completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Glioma | Phase 1 | Status: COMPLETED | Results posted: 2016-03-15